Doriane Rey 1/31/24 Doriane Rey 1/31/24

Rostrum, Southlake and OBIO® team up to evaluate a non-invasive, real time, bedside monitoring system to manage mechanically ventilated patients in the ICU

Arsheen Kaur 1/30/24 Arsheen Kaur 1/30/24

The Ottawa Hospital is the first in the world to use Vena Medical’s breakthrough stroke technology

Arsheen Kaur 1/30/24 Arsheen Kaur 1/30/24

Virica expands bioprocessing capabilities with Carleton University partnership

Arsheen Kaur 1/30/24 Arsheen Kaur 1/30/24

Swift Medical secures new financing round to further enhance its AI-based wound care technology

Arsheen Kaur 1/30/24 Arsheen Kaur 1/30/24

Eurofins CDMO Alphora announces the completion of a new pilot scale biologics development facility

Arsheen Kaur 1/30/24 Arsheen Kaur 1/30/24

Cohesys awarded $1.62M from MTEC to support BoneTape, a revolutionary fracture fixation technology

Arsheen Kaur 1/17/24 Arsheen Kaur 1/17/24

AI-Driven Clinical Trial Pre-Screening by K2 Medical Research, Magruder Eye Institute and RetiSpec

Arsheen Kaur 1/17/24 Arsheen Kaur 1/17/24

FluidAI Medical announces a $25M manufacturing investment in Ontario

Arsheen Kaur 1/17/24 Arsheen Kaur 1/17/24

KA Imaging’s Premium Dual-Energy Mobile System now available for sale in the U.S.

Doriane Rey 1/4/24 Doriane Rey 1/4/24

OBIO® Celebrates the Advancement of Women in Health Science with WiHI Seed Program and Leadership Awards

Arsheen Kaur 1/3/24 Arsheen Kaur 1/3/24

XPAN secures FDA 510(k) clearance and announces successful completion of initial human clinical cases in the U.S.

Arsheen Kaur 1/3/24 Arsheen Kaur 1/3/24

Seeing patients from the inside out: Realize Medical featured on national CTV News

Arsheen Kaur 1/3/24 Arsheen Kaur 1/3/24

OBIO® affiliated companies among selected funded projects to accelerate digital health innovations

Doriane Rey 12/19/23 Doriane Rey 12/19/23

Phyxable Partners with Right at Home and OBIO® to Revolutionize Senior Healthcare with Falls Prevention Program

Doriane Rey 12/7/23 Doriane Rey 12/7/23

OBIO® launches national health science technology training program powered by Upskill Canada

Doriane Rey 12/6/23 Doriane Rey 12/6/23

Microbix Clot-Buster Drug Fully-Funded for Return to U.S. Market

Doriane Rey 12/6/23 Doriane Rey 12/6/23

AmacaThera Closes Series A Extension to Advance Clinical Development of Long Acting, Localized, Non-Opioid Therapeutics to Improve Post-Surgery Patient Care

Doriane Rey 12/6/23 Doriane Rey 12/6/23

Phenomic AI Enters Strategic Collaborations with Boehringer Ingelheim & Astellas

Rostrum, Southlake and OBIO® team up to evaluate a non-invasive, real time, bedside monitoring system to manage mechanically ventilated patients in the ICU

The Ottawa Hospital is the first in the world to use Vena Medical’s breakthrough stroke technology

Virica expands bioprocessing capabilities with Carleton University partnership

Swift Medical secures new financing round to further enhance its AI-based wound care technology

Eurofins CDMO Alphora announces the completion of a new pilot scale biologics development facility

Cohesys awarded $1.62M from MTEC to support BoneTape, a revolutionary fracture fixation technology

AI-Driven Clinical Trial Pre-Screening by K2 Medical Research, Magruder Eye Institute and RetiSpec

FluidAI Medical announces a $25M manufacturing investment in Ontario

KA Imaging’s Premium Dual-Energy Mobile System now available for sale in the U.S.

OBIO® Celebrates the Advancement of Women in Health Science with WiHI Seed Program and Leadership Awards

XPAN secures FDA 510(k) clearance and announces successful completion of initial human clinical cases in the U.S.

Seeing patients from the inside out: Realize Medical featured on national CTV News

OBIO® affiliated companies among selected funded projects to accelerate digital health innovations

Phyxable Partners with Right at Home and OBIO® to Revolutionize Senior Healthcare with Falls Prevention Program

OBIO® launches national health science technology training program powered by Upskill Canada

Microbix Clot-Buster Drug Fully-Funded for Return to U.S. Market

AmacaThera Closes Series A Extension to Advance Clinical Development of Long Acting, Localized, Non-Opioid Therapeutics to Improve Post-Surgery Patient Care

Phenomic AI Enters Strategic Collaborations with Boehringer Ingelheim & Astellas

New technology aims to improve access to cancer care

QurCan to participate in Novo Nordisk's program